Michael J. Ambrogi, Chief Operating Officer at NovoCure Ltd (NVCR), sold 80,819 shares at $79.00 ($6.4M) on 2019-11-04, disclosed to the SEC on 2019-11-06.
Open-market sale of $6.4M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.00 | 10,069 | $795K | 12.5% |
| 2 | $79.00 | 33,793 | $2.7M | 41.8% |
| 3 | $79.00 | 36,957 | $2.9M | 45.7% |
| Total | $79.00 avg | 80,819 | $6.4M | 100% |
| Filing → |
| NVCR | SELL | 2020-03-10 | $316K | — | Filing → |
| NVCR | SELL | 2020-03-02 | $386K | — | Filing → |
| NVCR | SELL | 2020-02-26 | $1.9M | — | Filing → |